Brand Name Decsion 36C259-26-AP-2357 - Micromedex_Redacted.pdf

This is a Decision for Sole Source Award document authorizing a firm-fixed price purchase order for access to the Micromedex database at the Cheyenne VA Medical Center. The contract has a base year with four one-year option periods, for a total estimated value across all five years that is redacted in the document.

The justification for sole source award under RFO 12.102(a) is based on Micromedex's unique integration into the VA's Computerized Patient Record System (CPRS) and its specialized capabilities. Micromedex is the standard pharmaceutical decision support and toxicology management system used across VA Health Care Systems, providing comprehensive drug and medication information covering medication safety, drug interactions, alternative medicine and therapies, IV compatibility, formulary solutions, pediatric and neonatal evidence, and global drug information. The system also provides cloud service and IBM Watson technology that are unavailable from competitors and critical for preventing treatment delays and adverse outcomes in emergency situations. Two alternative vendors were considered and rejected: Pepid was determined to be more costly to integrate and lacks cloud service capability, while Lexicomp does not offer comparable products, cannot support IBM Watson technology, and switching would create patient safety concerns and care delays. The contracting officer, Danielle Kramer from the Network Contracting Office (NCO) 19, approved the sole source decision on March 24, 2026. The acquisition plan action ID is 36C259-26-AP-2357, with JOFOC tracking number FY26 – NCO 19 - 877.